Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2010
11/04/2010US20100278862 Nipah Virus Vaccines
11/04/2010US20100278849 Prostatic acid phosphatase antigens
11/04/2010US20100278848 Tumor antigen bfy3 for prevention and/or treatment of cancer
11/04/2010US20100278847 Mutually suppressive gene/inhibitor combinations for non-antibiotic selection of recombinant strains
11/04/2010US20100278842 Anti-ephb2 antibodies and methods using same
11/04/2010US20100278841 DOWN-REGULATION OF MORTALIN BY siRNA
11/04/2010US20100278839 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability
11/04/2010US20100278838 Epha2 monoclonal antibodies and methods of use thereof
11/04/2010US20100278832 Anti-bst2 antibody
11/04/2010US20100278831 Nogo Receptor-Mediated Blockade of Axonal Growth
11/04/2010US20100278830 Methods and systems for multi-antibody therapies
11/04/2010US20100278827 Concatameric immunoadhesion molecule
11/04/2010US20100278826 Designer Ubiquitin Ligases For Regulation Of Intracellular Pathogenic Proteins
11/04/2010US20100278825 Mammalian Receptor Proteins; Related Reagents and Methods
11/04/2010US20100278821 N-cadherin: target for cancer diagnosis and therapy
11/04/2010US20100278818 Antibody specific for the Tn antigen for the treatment of cancer
11/04/2010US20100278813 Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
11/04/2010US20100278809 Inhibitors of MRP4 for the Treatment of Vascular Disorders
11/04/2010US20100278800 Stem cell factor-like proteins and uses thereof
11/04/2010US20100278797 Pharmaceutical Composition and Method for Regulating Abnormal Cellular Proliferation
11/04/2010US20100278791 Adeno-associated virus serotype i nucleic acid sequences, vectors and host cells containing same
11/04/2010US20100278775 Plant Bioreactor For The Production Of Interleukin-24 Cytokine
11/04/2010US20100278774 Fusion molecules and il-15 variants
11/04/2010US20100278768 Compounds and Methods for Inhibiting Axillary Malodour
11/04/2010US20100276357 Method for extracting nucleic acid and nucleic acid-extracting apparatus
11/04/2010US20100275502 Rodenticide
11/04/2010DE19851415B4 Mutanter Transaktivator The mutant transactivator
11/04/2010DE112008003433T5 Pflanzen mit erhöhtem Ertrag (KO NUE) Plants having increased yield (KO NUE)
11/04/2010DE102009012169B3 Vorrichtung und Verfahren zum Herstellen eines Replikats oder eines Derivats aus einem Array von Molekülen und Anwendungen derselben Apparatus and method for producing a replica or a derivative of an array of molecules and applications thereof
11/04/2010DE10106493B4 Verfahren zur Herstellung von Nukleinsäuren Process for the preparation of nucleic acids
11/04/2010CA2795934A1 Polypeptides having xylanase activity and polynucleotides encoding same
11/04/2010CA2768045A1 Sensor for protein-type electron mediator
11/04/2010CA2760642A1 Anti-cadherin antibody
11/04/2010CA2760611A1 Dual-action inhibitors and methods of using same
11/04/2010CA2760589A1 Treatment of hemoglobin (hbf/hbg) related diseases by inhibition of natural antisense transcript to hbf/hbg
11/04/2010CA2760553A1 Monoclonal antibodies to influenza h1n1 virus and uses thereof
11/04/2010CA2760542A1 A non-target amplification method for detection of rna splice-forms in a sample
11/04/2010CA2760518A1 Epigenetic marker for the identification of natural killer cells
11/04/2010CA2760473A1 Method for producing a protein of interest using a novel fusion protein
11/04/2010CA2760429A1 Plants having enhanced yield-related traits and a method for making the same
11/04/2010CA2760315A1 Modified immunization vectors
11/04/2010CA2760275A1 Modification of the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof
11/04/2010CA2760274A1 A method for detection of human papillomavirus (hpv) type
11/04/2010CA2760266A1 Plants having enhanced yield-related traits and a method for making the same
11/04/2010CA2760244A1 Hepcidin binding nucleic acids
11/04/2010CA2760098A1 Mutants of francisella tularensis and uses thereof
11/04/2010CA2760042A1 Compositions and methods for modulating stem cells and uses thereof
11/04/2010CA2759994A1 Organisms for the production of 1,3-butanediol
11/04/2010CA2759911A1 Protein electron mediator
11/04/2010CA2759809A1 Manipulating fructan biosynthesis and enhancing plant biomass
11/04/2010CA2759400A1 Chimeric factor h binding proteins (fhbp) and methods of use
11/04/2010CA2759370A1 Method for the production of domain antibodies
11/04/2010CA2759273A1 Production of fatty acid esters
11/04/2010CA2759165A1 Concatamers for immunemodulation
11/04/2010CA2758928A1 Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure
11/04/2010CA2758592A1 Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
11/04/2010CA2756442A1 Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents
11/03/2010EP2246446A1 Method for quantification of target substance
11/03/2010EP2246443A1 Antisense modulation of PTP1B expression
11/03/2010EP2246434A1 A GNMT- knockout mouse model for depression, schiozophrenia and Alzheimer's disease
11/03/2010EP2246433A1 Concatamers for immune modulation
11/03/2010EP2246432A2 Methods and compositions capable of causing post-transcriptional silencing of gene expression in a synergic manner
11/03/2010EP2246430A1 Anti-adam-15 antibodies and utilization of the same
11/03/2010EP2246429A1 Non-human mammal model of epilepsy
11/03/2010EP2246428A1 Modified trna containing non-natural nucleotide and use thereof
11/03/2010EP2246427A1 Antibody capable of binding specifically to a -oligomer, and use thereof
11/03/2010EP2246426A1 Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody
11/03/2010EP2246425A1 REACTION DEVICE, REACTION METHOD AND METHOD OF SYNTHESIZING cDNA
11/03/2010EP2246424A1 Novel hydrogen peroxide-forming nadh oxidase, and dna encoding the same
11/03/2010EP2246423A1 Method for introducing foreign gene into early embryo of primate animal, and method for production of transgenic primate animal comprising the introduction method
11/03/2010EP2246422A1 Polynucleotide or analogue thereof, and gene expression regulation method using the polynucleotide or the analogue thereof
11/03/2010EP2246420A1 L-cysteine-producing bacterium, and method for production of l-cysteine
11/03/2010EP2246419A1 Novel mycovirus, attenuated strain of phytopathogenic fungus, plant disease controlling agent, method of producing mycovirus, method of attenuating phytopathogenic fungus and method of controlling plant disease
11/03/2010EP2246418A1 Lignan hydroxylase
11/03/2010EP2246417A1 Recombinantly modified plasmin
11/03/2010EP2246416A1 Mutated Abl kinase domains
11/03/2010EP2246413A2 Method for purifying plasmid DNA having pharmaceutical quality
11/03/2010EP2246362A2 Polymer conjugates of mutated neublastin
11/03/2010EP2246361A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/03/2010EP2246358A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
11/03/2010EP2246357A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
11/03/2010EP2245921A1 Novel stevia variety and method of producing sweetener
11/03/2010EP2245571A2 Methods for determining correlated residues in a protein or other biopolymer using molecular dynamics
11/03/2010EP2245195A2 Two stage enrichment of cell-free fetal dna in maternal plasma
11/03/2010EP2245173A2 Thermophilic and thermoacidophilic glycosylation genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
11/03/2010EP2245171A2 Cell lines and methods for making and using them
11/03/2010EP2245170A1 Zea mays aba signaling genes and methods of use
11/03/2010EP2245169A2 Plant genomic dna flanking spt event and methods for identifying spt event
11/03/2010EP2245168A2 Plants having enhanced yield-related traits and a method for making the same
11/03/2010EP2245167A1 Maize leaf- and stalk-preferred promoter
11/03/2010EP2245166A1 Very long chain polyunsaturated fatty acids, methods of production, and uses
11/03/2010EP2245165A1 Conditional-stop dimerizable caspase transgenic animals
11/03/2010EP2245164A1 Multiple promoter platform for protein production
11/03/2010EP2245163A2 Cell populations for polypeptide analysis and uses of same
11/03/2010EP2245162A2 Isolated alcohol dehydrogenase enzymes and uses thereof
11/03/2010EP2245161A1 Method for producing sclareol
11/03/2010EP2245160A1 Cell surface display of proteins
11/03/2010EP2245159A2 Compositions and methods for inhibiting expression of factor vii gene
11/03/2010EP2245158A2 Impaired wound healing compositions and treatments
11/03/2010EP2245157A1 Method for the extraction and purification of nucleic acids on a membrane
1 ... 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 ... 4023